OncoSil Medical Ltd. announced that Chief Financial Officer (CFO) Karl Pechmann has resigned from his position to take on the CFO role at another ASX listed company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 AUD | 0.00% | 0.00% | -44.44% |
06-03 | Oncosil Medical Treats 200th Pancreatic Cancer Patient with Proprietary Device | MT |
05-23 | Oncosil Medical Enters Distribution Agreement with Abdulla Fouad Group for Saudi Arabia | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-44.44% | 11.13M | |
+42.60% | 748B | |
+33.13% | 598B | |
-5.74% | 356B | |
+17.79% | 325B | |
+3.37% | 283B | |
+17.22% | 245B | |
+9.27% | 211B | |
-3.72% | 209B | |
+6.74% | 165B |
- Stock Market
- Equities
- OSL Stock
- News OncoSil Medical Limited
- Oncosil Medical Ltd Announces Resignation of Karl Pechmann as Chief Financial Officer